No Cover Image

Journal article 756 views 97 downloads

Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor

Mark Bannister Orcid Logo, Kenneth T. MacLeod Orcid Logo, Christopher George Orcid Logo

British Journal of Pharmacology, Volume: 179, Issue: 11, Pages: 2558 - 2563

Swansea University Authors: Mark Bannister Orcid Logo, Christopher George Orcid Logo

Check full text

DOI (Published version): 10.1111/bph.15718

Published in: British Journal of Pharmacology
ISSN: 0007-1188 1476-5381
Published: Wiley 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa58568
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2021-11-08T10:30:35Z
last_indexed 2022-05-18T03:33:01Z
id cronfa58568
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-05-17T10:12:55.4659363</datestamp><bib-version>v2</bib-version><id>58568</id><entry>2021-11-08</entry><title>Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor</title><swanseaauthors><author><sid>cd153d7ad8b74a44d0401211d66d1e20</sid><ORCID>0000-0002-0865-5912</ORCID><firstname>Mark</firstname><surname>Bannister</surname><name>Mark Bannister</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>a2e211f7bd379c81e9c393637803a0a0</sid><ORCID>0000-0001-9852-1135</ORCID><firstname>Christopher</firstname><surname>George</surname><name>Christopher George</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-11-08</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>British Journal of Pharmacology</journal><volume>179</volume><journalNumber>11</journalNumber><paginationStart>2558</paginationStart><paginationEnd>2563</paginationEnd><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0007-1188</issnPrint><issnElectronic>1476-5381</issnElectronic><keywords>anti-arrhythmic drugs; cardiac arrhythmias; catecholaminergic polymorphic ventricular tachycardia; flecainide; mechanism; ryanodine receptor calcium release channel</keywords><publishedDay>1</publishedDay><publishedMonth>6</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-06-01</publishedDate><doi>10.1111/bph.15718</doi><url/><notes>Mini Review</notes><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>Wellcome Trust, British Heart Foundation</funders><lastEdited>2022-05-17T10:12:55.4659363</lastEdited><Created>2021-11-08T10:21:32.2229138</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Mark</firstname><surname>Bannister</surname><orcid>0000-0002-0865-5912</orcid><order>1</order></author><author><firstname>Kenneth T.</firstname><surname>MacLeod</surname><orcid>0000-0003-0633-1591</orcid><order>2</order></author><author><firstname>Christopher</firstname><surname>George</surname><orcid>0000-0001-9852-1135</orcid><order>3</order></author></authors><documents><document><filename>58568__21440__c448d43af3344b8790734d80e9676812.pdf</filename><originalFilename>58568.AAM..pdf</originalFilename><uploaded>2021-11-08T10:42:07.9102976</uploaded><type>Output</type><contentLength>567748</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2022-10-26T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2022-05-17T10:12:55.4659363 v2 58568 2021-11-08 Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor cd153d7ad8b74a44d0401211d66d1e20 0000-0002-0865-5912 Mark Bannister Mark Bannister true false a2e211f7bd379c81e9c393637803a0a0 0000-0001-9852-1135 Christopher George Christopher George true false 2021-11-08 BMS Journal Article British Journal of Pharmacology 179 11 2558 2563 Wiley 0007-1188 1476-5381 anti-arrhythmic drugs; cardiac arrhythmias; catecholaminergic polymorphic ventricular tachycardia; flecainide; mechanism; ryanodine receptor calcium release channel 1 6 2022 2022-06-01 10.1111/bph.15718 Mini Review COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University Wellcome Trust, British Heart Foundation 2022-05-17T10:12:55.4659363 2021-11-08T10:21:32.2229138 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Mark Bannister 0000-0002-0865-5912 1 Kenneth T. MacLeod 0000-0003-0633-1591 2 Christopher George 0000-0001-9852-1135 3 58568__21440__c448d43af3344b8790734d80e9676812.pdf 58568.AAM..pdf 2021-11-08T10:42:07.9102976 Output 567748 application/pdf Accepted Manuscript true 2022-10-26T00:00:00.0000000 true eng
title Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
spellingShingle Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
Mark Bannister
Christopher George
title_short Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
title_full Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
title_fullStr Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
title_full_unstemmed Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
title_sort Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
author_id_str_mv cd153d7ad8b74a44d0401211d66d1e20
a2e211f7bd379c81e9c393637803a0a0
author_id_fullname_str_mv cd153d7ad8b74a44d0401211d66d1e20_***_Mark Bannister
a2e211f7bd379c81e9c393637803a0a0_***_Christopher George
author Mark Bannister
Christopher George
author2 Mark Bannister
Kenneth T. MacLeod
Christopher George
format Journal article
container_title British Journal of Pharmacology
container_volume 179
container_issue 11
container_start_page 2558
publishDate 2022
institution Swansea University
issn 0007-1188
1476-5381
doi_str_mv 10.1111/bph.15718
publisher Wiley
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2022-06-01T04:15:12Z
_version_ 1763754022942015488
score 11.037603